Two Sigma Securities’s Werewolf Therapeutics HOWL Stock Holding History
Bought
Maintained
Sold
Other funds holding HOWL
LCM
DF
Two Sigma Securities's HOWL Position: Q3 2026 in Review
Two Sigma Securities opened a new position in Werewolf Therapeutics (HOWL) in Q3 2026: 20,578 shares worth $19K. The stake represents ﹤0.01% of the portfolio and ranks #1502 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in HOWL as recently as Q2 2025.
Two Sigma Securities first reported a position in HOWL in Q4 2024 and has held it in 3 quarters since. The position peaked at $24.4K in Q2 2025. 46 funds tracked by Wall St. Rank hold HOWL as of Q3 2026.
- Two Sigma Securities held 20,578 shares of Werewolf Therapeutics worth $19K as of Q3 2026.
- Werewolf Therapeutics was a new Two Sigma Securities position in Q3 2026.
- Werewolf Therapeutics made up ﹤0.01% of Two Sigma Securities's portfolio in Q3 2026, its #1502 holding.
- Two Sigma Securities first reported a position in Werewolf Therapeutics in Q4 2024 and has held it in 3 quarters since.
- Two Sigma Securities's Werewolf Therapeutics position peaked at $24.4K in Q2 2025.
- 46 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q3 2026.
Based on Two Sigma Securities's 13F filing for Q3 2026, filed 16 Nov 2026.